RxDoctor Payments Data

Robert Bonomo

Infectious Disease · Cleveland, OHNPI 1255496592

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,325 of the $5,336 with a category attached, or 99.8%. Paratek Pharmaceuticals, Inc. accounts for 64.7% of it on its own, with 1 other manufacturer making up the rest.

$5,336in general payments, 2019–2025

Across 3 payments — averaging $1778.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$3K
  • Merck$2K
$1,021,833in research payments, 2019–2025

Across 18 payments — averaging $56,769 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$824K
  • Shionogi Inc$102K
  • F. Hoffmann-la Roche AG$95K

What the payments were for

  • Consulting fees$5,325100%
  • Education$110%

General payments by program year

20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Paratek Pharmaceuticals, Inc.1$3,450
Merck2$1,886

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,336 in reported general payments places this provider in the 85th percentile of 308 infectious disease providers in Ohio.

See all infectious disease providers in Ohio

Other infectious disease in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →